Study: Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial
Catching these changes early, during the perimenopause window, is when intervention can make the biggest difference
Back in 1985, the National Kidney Foundation recommended that labels of over-the-counter NSAIDs display a warning about their potential to cause kidney damage (NKF 1985), but these drugs are often still considered benign by consumers (Jang 2014
These drugs mimic a naturally occurring hormone in the body that regulates blood sugar, slows digestion, and signals a sense of fullness to the brain
For Long Islanders considering weight loss solutions, the dangers of compounded drugs far outweigh any potential benefits
- 30x Concentrated Berberine Extract